Bernabe Drug Study

7/27/2019 Bernabe Drug Study

1/6

GenericName

Brandname

Classification

Howsupplie

d

Dosage

andFrequency

MechanismOf Action

Indication Contraindication Side effects Nursing Responsibilities

Tramadol Dolotral

Opiates andAntagonists

ampule 500mg,IVTT

Q8hr

Centrally actinganalgesic notchemically related toopioids but binds tomu-opioid receptorsand inhibits reuptakeof norepinephrine andserotonin

Indicated topatient whosuffermoderateto severepain

Contraindicated tohypersensitivity onthis drug-acute intoxicationwith alcohol,hypnotics, centralacting analgesic,opioids orpsychotropicagents

Vasodilation,Dizziness/vertigo,Headache,Somnolence,Stimulation,anxiety,Coordinationdisturbances,Euphoria,Nervousness,Sleepdisorder,Seizures,Pruritus,Nausea,Pain,

Anorexia,flatulence

BEFORE: Assess patient I any

potential problem Check doctors order on

patient chart Observe the rights of drug

administration Check any known allergies

on drug Check the right drug for the

right patient Check pain score felt by the

patient Educate patient regarding

the drug and its therapeuticeffects

DURING: Administer the drug when

pain occur as prescribed bythe Physician

AFTER: Instruct patient to change

position slowly to preventorthostatic hypotension

Instruct patient to avoidalcohol and OTC medicationwithout medical advice

Monitor intake and output,decreasing output mayindicate retention\Monitor forCNS changes: dizziness,drowsiness, hallucinations

Instruct patient to report anydrug adverse reactions

Document the given drug onMAR.


2/6

GenericName

Brandname

Classification

Howsupplie

d

Dosage

andFrequency

MechanismOf Action

IndicationContraindicati

onSide effects Nursing Responsibilities

Ranitidine Zantac

H2-Receptor

Antagonists

ampule 50mgIVTTq8h

Inhibits histamine at H2receptor site in thegastric parietal cells,

which inhibits gastricacid secretion

Indicated topatient withvarious gastro-

intestinal (GI)disorder,prophylaxis ofGIhemorrhagefrom stressulceration

Contraindicatedto patienthypersensitivity

on this drug,history of acuteporphyria, longterm therapy

Cardiacarrhythmias,Bradycardia,

Fatigue,Dizziness,Hallucinations,Insomnia,

Abdominal,discomfort,Constipation,Pancreatitis,Diarrhea,Nausea,Vomiting

BEFORE: Assess patient of any


patient chart Observe the rights of drugadministration

Check any known allergieson drug

Check Vital Signs Check the right drug for the

right patient Educate patient regarding


DURING: Administer the drug as

prescribedAFTER:

Monitor AST, ALT,serum/creatinine

Instruct patient to moveslowly drug has effect ofdizziness

Instruct patient to reportchest pain or any drugadverse reactions

Document the givenmedication on MAR


3/6

GenericName

Brandname

Classification

Howsupplie

d

Dosage

andFrequency

MechanismOf Action



Oxacillin Prostaphlin

Penicillin ampule 1gmIVTTq8h

Interferes with the cellwall replication ofsusceptible organisms;osmotic ally unstable

cell wall swell, burstsfrom osmotic pressure

Treatment ofinfectionscaused bypenicillinase -

producingstaphylococci;initial therapyof suspectedstaphylococcalinfection

Contraindicatedto patienthypersensitivityto penicillin

Lethargy,Hallucinations,

Anxiety,Depression,

Twitching,Coma,Seizures,Nausea,Vomiting,Diarrhea,

Abdominalpain,Glossitis,Coitis,Vaginitis,Serumsickness



patient chart

Observe the rights of drugadministration



right patient Assess the result in culture

and sensitivity test Educate patient regarding



prescribedAFTER:

Monitor for bleeding;ecchymosis, bleedinggums, hematuria

Monitor bowel patterneveryday

Monitor for overgrowth ofinfection

Monitor blood studies: AST,ALT, CBC

Instruct patient to reportany drug adverse reactions

Document the given

medication on MAR


4/6

GenericName

Brandname

Classification

Howsupplie

d

Dosage

andFrequency

MechanismOf Action



ketorolac Torad

ol

Nonsteroida

l anti-

inflammator

y agents,nonopioid

analagesics

ampule 10 mgIVTTq6h

-Inhibits prostaglandin

synthesis, producing

peripherally mediated

analgesia- Also has antipyretic

and anti-inflammatory

properties.

- Therapeutic

effect:Decreased pain

Short term

management

of pain (not to

exceed 5 daystotal for all

routes

combined)

Hypersensitivity

- Cross-

sensitivity with

other NSAIDs

may existPre-or

perioperative

use

- Known alcohol

intoleranceUse

cautiously in:

1) History of GI

bleeding

2) Renal impair-

ment (dosage

reduction may

be required)3)

Cardiovascular

disease

CNS:

1) drowsiness

2) abnormal

thinking3) dizziness

4) euphoria

5) headache-

GI:

1) GI Bleeding

2) abnormal

taste

3) diarrhea

4) dry mouth

5) dyspepsia

6) GI pain7) nausea

8)vomiting



patient chart







- Assess pain (note type,

location, and intensity)

prior to and 1-2 hr

following administration.


prescribedAFTER:




5/6

GenericName

Brandname

Classification

Howsupplie

d

Dosage

andFrequency

MechanismOf Action



paracetamol Tylenol

AntipyreticAnalgesic

ampule 39 mgIVTTq6h

Antipyretic:

Reduces feverbyacting directly

onthehypothalamich

eat-regulatingcenter

tocausevasodilati

onandsweating,

whichhelpsdissipateheat.

Analgesic:Siteand

mechanismofaction unclea

Analgesic-antipyretic

inpatients with

aspirinallergy,

hemostaticdisturbances,bleedingdiatheses, upper

GIdisease, gouty arthritis-

Arthritis and

rheumaticdisorders

involvingmusculoskeletal

pain (butlacks c linical ly

significantantirheumati

c and anti-

inflammatory effects)-

Common cold, flu,

otherviral and

bacterialinfections

with pain andfever-

Unlabeled

use:Prophylactic for

childrenreceiving DPT

vaccinationto reduce

incidence of fever and

pain

-Contraindicated

withallergy to

acetaminophen.

- Use cautiously

withimpairedhepatic

function,chronic

alcoholism,pregna

ncy, lactation

Stimulation,

drowsiness,

nausea,

vomiting,abdominal

pain,

hepatotoxicity,

hepatic

seizure(overdo

se, Renal

failure(high,

prolonged

doses),

leucopenia,

neutropenia,

hemolytic

anemia (long

term use)

thrombocytop

enia,

pancytopenia,

rash, urticaria,

hypersensitivit

y, cyanosis,

anemia,

jaundice, CNS,

stimulation,

delirium

followed by

vascular

collaps,

convulsions,

coma, death.



patient chart








prescribedAFTER:




6/6

Documents

Bernabe Drug Study